Niemann Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
Niemann Capital Management's XBI Position: Q3 2015 in Review
Niemann Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2015, closing a stake of 143,283 shares — an estimated $12M sold.
Niemann Capital Management first reported a position in XBI in Q2 2013 and held it in 4 quarters. The position peaked at $12M in Q2 2015. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.
- Niemann Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2015 after selling out during the quarter.
- Niemann Capital Management sold 143,283 State Street SPDR S&P Biotech ETF shares in Q3 2015, an estimated $12M.
- Niemann Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 4 quarters.
- Niemann Capital Management's State Street SPDR S&P Biotech ETF position peaked at $12M in Q2 2015.
- 196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.
Based on Niemann Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.